Brief: Cerenis Therapeutics And University Of North Texas To Develop New Products

Abionyx Pharma SA

29/05/2018 06:39

May 29 (Reuters) - CERENIS THERAPEUTICS HOLDING SA
 CEREN.PA :
    * CERENIS THERAPEUTICS AND UNIVERSITY OF NORTH TEXAS HEALTH
SCIENCE CENTER ANNOUNCE A STRATEGIC INITIATIVE TO DEVELOP NEW
HDL-BASED PHARMACEUTICAL PRODUCTS
    * JOINT PROGRAM TO DEVELOP NEW HDL TECHNOLOGIES FOR DRUG
DELIVERY
    * CREATION OF PREMIER INITIATIVE FOR DEVELOPING UNIQUE HDL
PLATFORM TECHNOLOGIES

Source text for Eikon:  ID:nBw4RlPy3a 
Further company coverage:  CEREN.PA 

 (Gdynia Newsroom:)
 ((Gdynia.newsroom@thomsonreuters.com; +48 58 772 09 20;))